According to the WHO, the main markers differentiating APL from other AML are HLA-DR, CD34, the homogeneous and strong expression of CD33, negative or weakly expressed CD15, and the expression of CD64 that is common in APL. The gene discussed is CD34; the disease is acute promyelocytic leukemia.